# Non-Interventional Multicentre Post-market Study of Ectoin® Vaginal Gel for Symptomatic Treatment of Vaginal Atrophy

> **NCT04910906** · — · COMPLETED · sponsor: **Bitop AG** · enrollment: 155 (actual)

## Conditions studied

- Vaginal Atrophy

## Interventions

- **DEVICE:** Ectoin® Vaginal Gel

## Key facts

- **NCT ID:** NCT04910906
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2022-02-09
- **Final completion:** 2022-02-09
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04910906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04910906, "Non-Interventional Multicentre Post-market Study of Ectoin® Vaginal Gel for Symptomatic Treatment of Vaginal Atrophy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04910906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*